Title : CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.

Pub. Date : 2012 Sep

PMID : 22947591






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens
2 A population pharmacokinetic analysis showed that postoperative days, sex, and CYP3A5 genotype significantly affected the pharmacokinetics of cyclosporine. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens
3 CONCLUSIONS: Using the present model to calculate the dose of cyclosporine with CYP3A5 genotyping can be possible for the patients whose cyclosporine concentration is not within the therapeutic range even with therapeutic drug monitoring. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens
4 CONCLUSIONS: Using the present model to calculate the dose of cyclosporine with CYP3A5 genotyping can be possible for the patients whose cyclosporine concentration is not within the therapeutic range even with therapeutic drug monitoring. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens